Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
BioProcess Internation...BioProcess International US West
Not Confirmed
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
09-11 March, 2026
Not Confirmed
Not Confirmed
09-11 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BioProcess Internation...BioProcess International US West
Industry Trade Show
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
09-11 March, 2026
Industry Trade Show
Not Confirmed
09-11 March, 2026
Digital content

05 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/05/3233021/0/en/Propanc-Biopharma-Unveils-PRP-A-Game-Changing-Proenzyme-Therapy-Poised-to-Challenge-Standard-Cancer-Treatments-in-the-3-Billion-Pancreatic-Cancer-Market.html

27 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/27/3226520/0/en/Propanc-Biopharma-Accelerates-IP-Momentum-Files-Fourth-Provisional-Patent-Application-in-Just-Two-Months-Strengthening-Global-Protection-for-Breakthrough-Proenzyme-Formulations.html

20 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/20/3221748/0/en/Propanc-Biopharma-Files-New-Provisional-Patent-Application-for-Methods-of-Producing-Trypsinogen-Chymotrypsinogen-with-IP-Australia.html

15 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/15/3219573/0/en/Propanc-Biopharma-Explains-How-PRP-Could-Impact-Pancreatic-Cancer.html

13 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/13/3217829/0/en/Propanc-Biopharma-Provides-Shareholder-Update.html

04 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/04/3199812/0/en/Propanc-Biopharma-Investigates-Mesenchymal-Drift-to-Reverse-Chronic-Diseases-Defined-by-Altos-Labs.html
ABOUT THIS PAGE